Regulation of antibody responses via antibodies, complement, and Fc receptors

Annual Review of Immunology

Volumn 18, Issue , 2000, Pages 709-737

  Heyman, Birgitta ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

CD23; IgE; IgG; IgM; Immune complex

Indexed keywords

ANTIBODY; ANTIGEN; CD23 ANTIGEN; COMPLEMENT; EPITOPE; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; B LYMPHOCYTE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMALS; ANTIBODIES; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RECEPTORS, FC;

EID: 0034046181     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.18.1.709     Document Type: Review

References (175)

1. Henry C, Jerne N. 1968. Competition of 19S and 7S antigen receptors in the regulation of the primary immune response. J. Exp. Med. 128:133-52
2. Brüggemann M, Rajewsky K. 1982. Regulation of the antibody response against hapten-coupled erythrocytes by monoclonal anti-hapten antibodies of various isotypes. Cell. Immunol. 71:365-73
3. Heyman B, Wigzell H. 1984. Immuno-regulation by monoclonal sheep erythrocyte specific IgG antibodies: Suppression is correlated to level of antigen binding and not to isotype. J. Immunol. 132:1136-43
4. Karlsson MCI, Wernersson S, Diaz de Ståhl T, Gustavsson S, Heyman B. 1999. Efficient IgG-mediated suppression of primary antibody responses in Fcγ receptor-deficient mice. Proc. Natl. Acad. Sci. USA 96:2244-49
5. Clarke CA, Donohoe WTA, Woodrow JC, Finn R, Krevans JR, Kulke W, Lehane D, Sheppard PM. 1963. Further experimental studies on the prevention of Rh haemolytic disease. Br. Med. J. 1:979-84
6. Bowman JM. 1988. The prevention of Rh immunization. Transfus. Med. Rev. 2:129-50
7. Heyman B, Pilström L, Shulman MJ. 1988. Complement activation is required for IgM-mediated enhancement of the antibody response. J. Exp. Med. 167:1999-2004
8. Ehrenstein MR, O'Keefe TL, Davies SL, Neuberger MS. 1998. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc. Natl. Acad. Sci. USA 95:10089-93
9. Boes M, Esau C, Fischer MB, Schmidt T, Carroll M, Chen J. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160:4776-87
10. Bitter-Suermann D, Burger R. 1989. C3 deficiencies. Curr. Top. Microbiol. Immunol. 153:223-33
11. Heyman B. 1994. The role of complement receptors in the regulation of the immune response. In New Aspects of Complement Structure and Function, ed. A Erdei, pp. 59-69. Austin, TX: Landes
12. Carroll MC. 1998. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16:545-68
13. Dempsey PW, Allison MED, Akkaraju S, Goodnow CC, Fearon DT. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348-50
14. Villiers M-B, Villiers CL, Laharie A-M, Marche PN. 1999. Amplification of the antibody response by C3b complexed to antigen through an ester link. J. Immunol. 162:3647-52
15. Baiu DC, Prechl J, Tchorbanov A, Molina HD, Erdei A, Sulica A, Capel PJA, Hazenbos WLW. 1999. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors. J. Immunol. 162:3125-30
16. Coulie P, Van Snick J. 1985. Enhancement of IgG anti-carrier responses by IgG2-anti-hapten antibodies in mice. Eur. J. Immunol. 15:793-98
17. Wernersson S, Karlsson M, Dahlström J, Mattsson R, Verbeek JS, Heyman B. 1999. IgG-mediated enhancement of Ab responses is low in FcRγ chain deficient mice and increased in FcγRII deficient mice. J. Immunol. 163:618-22
18. Heyman B, Liu T, Gustavsson S. 1993. In vivo enhancement of the specific antibody response via the low affinity receptor for IgE. Eur. J. Immunol. 23:1739-42
19. Gustavsson S, Hjulström S, Liu T, Heyman B. 1994. CD23/IgE-mediated regulation of the specific antibody response in vivo. J. Immunol. 152:4793-800
20. Fujiwara H, Kikutani H, Suematsu S, Naka T, Yoshida K, Yoshida K, Tanaka T, Suemura M, Matsumoto N, Kojima S, Kishimoto T, Yoshida N. 1994. The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc. Natl. Acad. Sci. USA 91:6835-39
21. Gessner JE, Heiken H, Tamm A, Schmidt RE. 1998. The IgG Fc receptor family. Ann. Hematol. 76:231-48
22. Mossalayi MD, Arock M, Debre P. 1997. CD23/FcεRII: signaling and clinical implication. Int. Rev. Immunol. 16:129-46
23. Mudde GC, Bheekha R, Bruijnzeel-Koomen CAFM. 1995. Consequences of IgE/CD23-mediated antigen presentation in allergy. Immunol. Today 16:380-83
24. Phillips NE, Parker DC. 1984. Crosslinking of B lymphocyte Fcγ receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J. Immunol. 132:627-32
25. Bijsterbosch MK, Klaus GGB. 1985. Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors. J. Exp. Med. 162:1825-27
26. Amigorena S, Bonnerot C, Drake JR, Choquet D, Hunziker W, Guillet J-G, Webster P, Sautes C, Mellman I, Fridman WH. 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 256:1808-12
27. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV. 1994. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling. Nature 368:70-73
28. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV. 1996. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379:346-49
29. Uhr JW, Möller G. 1968. Regulatory effect of antibody on the immune response. Adv. Immunol. 8:81-127
30. Wiersma EJ. 1991. Effects of IgG antibodies and complement on the immune response. PhD thesis. Uppsala Univ., Uppsala, Sweden. 54 pp.
31. Heyman B. 1996. Complement and Fc receptors in regulation of the antibody response. Immunol. Lett. 54:195-99
32. Dennert G. 1973. Effects of IgM on the in vivo and in vitro immune response. Proc. Soc. Exp. Biol. Med. 143:889-93
33. Wason WM. 1973. Regulation of the immune response with antigen specific IgM antibody: a dual role. J. Immunol. 110:1245-52
34. Powell R, Hutchings P, Cooke A, Lydyard PM. 1982. Antibody mediated regulation of immune responses. I. Enhancement of specific antibody responses through IgM antibodies. Immunol. Lett. 4:253-58
35. Wiersma EJ. 1992. Enhancement of the antibody response to protein antigens by specific IgG under different experimental conditions. Scand. J. Immunol. 36:193-200
36. Pollack W, Gorman JG, Freda VJ, Ascari WQ, Allen AE, Baker WJ. 1968. Results of clinical trials of RhoGAM in women. Transfusion 8:151-53
37. Chan PL, Sinclair NR. 1973. Regulation of the immune response. VI. Inability of F(ab')2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression. Immunology 24:289-310
38. Whited Collisson E, Andersson B, Rönnholm M, Lamon E. 1983. Potentiation of antibody responses by specific IgM: specificity and thymus dependency. Cell. Immunol. 79:44-55
39. Heyman B, Andrighetto S, Wigzell H. 1982. Antigen dependent IgM-mediated enhancement of the sheep erythrocyte response in mice: evidence for induction of B cells with specificities other than that of the injected antibodies. J. Exp. Med. 155:994-1009
40. Klaus GGB. 1979. Generation of memory cells. III. Antibody class requirements for the generation of B-memory cells by antigen-antibody complexes. Immunology 37:345-51
41. Pearlman DS. 1967. The influence of antibodies on immunologic responses: the effect on the response to particulate antigen in the rabbit. J. Exp. Med. 126:127-48
42. Wiersma EJ, Nose M, Heyman B. 1990. Evidence of IgG-mediated enhancement of the antibody response in mice without classical pathway complement activation. Eur. J. Immunol 20:2585-89
43. Gustavsson S, Hjulström-Chomez S, Lidström B-M, Ahlborg N, Andersson R, Heyman B. 1998. Impaired antibody responses in H-2Ab mice. J. Immunol. 161:1765-71
44. Greenbury CL, Moore DH. 1968. Nonspecific antibody-induced suppression of the immune response. Nature 219:526-27
45. Whited Collisson E, Andersson B, Lamon EW. 1979. Modulation of hapten-specific responses with anticarrier antibody. I. Differential effects of IgM and IgG anticarrier on primary direct and indirect hapten-specific plaque-forming cells. Proc. Soc. Exp. Biol. Med. 162:194-98
46. Enriques-Rincon F, Klaus GGB. 1984. Differing effects of monoclonal anti-hapten antibodies on humoral responses to soluble or particulate antigens. Immunology 52:129-36
47. Whited Collisson E, Andersson B, Lamon EW. 1984. Avidities of hapten-specific antibodies when the responses are modulated by anti-carrier antibodies. Immunology 53:443-49
48. Wiersma EJ, Coulie PG, Heyman B. 1989. Dual immunoregulatory effects of monoclonal IgG-antibodies: suppression and enhancement of the antibody response. Scand. J. Immunol. 29:439-48
49. Brody NI, Walker JG, Siskind GW. 1967. Studies on the control of antibody synthesis: interaction of antigenic competition and suppression of antibody formation by passive antibody on the immune response. J. Exp. Med. 126:81-91
50. Möller G. 1985. Antibody-mediated suppression of the immune response is determinant specific. Eur. J. Immunol. 15:409-12
51. Quintana IZ, Silveira AV, Möller G. 1987. Regulation of the antibody response to sheep erythrocytes by monoclonal IgG antibodies. Eur. J. Immunol. 17:1343-49
52. Möller G, Wigzell H. 1965. Antibody synthesis at the cellular level: antibody-induced suppression of 19S and 7S antibody responses. J. Exp. Med. 121:969-89
53. Schrader JW. 1973. Regulation of the immune response by IgM antibody: a paradoxical suppression of the in vitro primary immune response to sheep erythrocytes by IgM. Aust. J. Exp. Biol. Med. Sci. 51:333-46
54. Takizawa F, Adamczewski M, Kinet J-P. 1992. Identification of the low affinity receptor for immunoglobulin E on mouse mast cells and macrophages as FcγRII and FcγRIII. J. Exp. Med. 176:469-76
55. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV. 1994. FcRγ chain deletion results in pleiotrophic effector cell defects. Cell 76:519-29
56. Heyman B, Wigzell H. 1985. IgM enhances and IgG suppresses immunological memory in mice. Scand. J. Immunol. 21:255-66
57. Bystryn J-C, Graf MW, Uhr JW. 1970. Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion. J. Exp. Med. 132:1279-87
58. Kappler JW, Hoffman M, Dutton RW. 1971. Regulation of the immune response. I. Differential effect of passively administered antibody on the thymus-derived and bone marrow-derived lymphocytes. J. Exp. Med. 134:577-87
59. Sinclair NR. 1969. Regulation of the immune response. I. Reduction in ability of specific antibody to inhibit longlasting IgG immunological priming after removal of the Fc fragment. J. Exp. Med. 129:1183-201
60. Dresser DW. 1990. Feedback by early and late primary antisera on the primary and secondary adoptive immune responses of mice to burro erythrocytes. Cell. Immunol. 127:405-19
61. Cerottini JC, McConahey PJ, Dixon FJ. 1969. The immunosuppressive effect of passively administered antibody IgG fragments. J. Immunol. 102:1008-15
62. Strannegård Ö, Belin L. 1970. Suppression of reagin synthesis in rabbits by passively administered antibody. Immunology 20:775-85
63. Krieger N, Pesce A, Michael JG. 1983. Immunoregulation of the anti-bovine serum albumin response by polyclonal and monoclonal antibodies. Cell. Immunol. 80:279-87
64. Walker JG, Siskind GW. 1968. Studies on the control of antibody synthesis: effect of antibody affinity upon its ability to suppress antibody formation. Immunology 14:21-28
65. Tao TW, Uhr JW. 1966. Capacity of pepsin-digested antibody to inhibit antibody formation. Nature 212:208-9
66. Sinclair NR, Lees RK, Elliott EV. 1968. Role of the Fc fragment in the regulation of the primary immune response. Nature 220:1048-49
67. Daëron M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15:203-34
68. Heyman B. 1990. Fc-dependent IgG-mediated suppression of the antibody response: fact or artefact? Scand. J. Immunol. 31:601-7
69. Heyman B, Wiersma E, Nose M. 1988. Complement activation is not required for IgG-mediated suppression of the antibody response. Eur. J. Immunol. 18: 1739-43
70. Heyman B, Nose M, Weigle WO. 1985. Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression. J. Immunol. 134:4018-23
71. Heyman B. 1989. Inhibition of IgG-mediated immunosuppression by a monoclonal anti-Fc-receptor antibody. Scand. J. Immunol. 29:121-26
72. Heyman B. 1999. Antibody feedback suppression: towards a unifying concept? Immunol. Lett. 68:41-45
73. Junghans RP, Anderson CL. 1996. The protection receptor for IgG catabolism is the beta-2-microglobulin-containing neonatal intestinal transport receptor. Proc. Natl. Acad. Sci. USA 93:5512-16
74. Amigorena S, Bonnerot C, Choquet D, Fridman WF, Teillaud J-L. 1989. FcγRII expression in resting and activated B lymphocytes. Eur. J. Immunol. 19:1379-85
75. Daëron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH. 1995. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3:635-46
76. Daëron M, Malbec O, Latour S, Arock M, Fridman WH. 1995. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J. Clin. Invest. 95:577-85
77. Minskoff SA, Matter K, Mellman I. 1998. FcγRII-B1 regulates the presentation of B cell receptor-bound antigens. J. Immunol. 161:2079-83
78. Wagle NM, Faassen AE, Kim JH, Pierce SK. 1999. Regulation of B cell receptor-mediated MHC class II antigen processing by FcγRIIB1. J. Immunol. 162:2732-40
79. Hunter S, Indik ZK, Kim MK, Cauley MD, Park JG, Schreiber AD. 1998. Inhibition of Fcγ receptor-mediated phagocytosis by a nonphagocytic Fcγ receptor. Blood 91:1762-68
80. Ujike A, Ishikawa Y, Ono M, Yuasa T, Yoshino T, Fukumoto M, Ravetch JV, Takai T. 1999. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J. Exp. Med. 189:1573-79
81. Clynes R, Maizes JS, Guinamard R, Ono M, Takai T, Ravetch JV. 1999. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189:179-85
82. Yuasa T. 1999. Deletion of Fcγ receptor IIB renders H-2b mice susceptible to collagen-induced arthritis. J. Exp. Med. 189:187-94
83. Stoner RD, Terres G. 1963. Enhanced antitoxin responses in irradiated mice elicited by complexes of tetanus toxoid and specific antibody. J. Immunol. 91:761-70
84. Stoner RD, Terres G, Hess MW. 1975. Early and enhanced antitoxin responses elicited with complexes of tetanus toxoid and specific mouse and human antibodies. J. Infect. Dis. 1975:230-38
85. Klaus GGB. 1978. The generation of memory cells. II. Generation of B memory cells with preformed antigen-antibody complexes. Immunology 34:643-52
86. Gustavsson S, Chomez S, Heyman B. 1999. Low responsiveness to immunization with immunoglobulin E/antigen and immunoglobulin G/antigen complexes in H-2Ab mice. Scand. J. Immunol. 50:45-51
87. Terres G, Habicht GS, Stoner RD. 1974. Carrier-specific enhancement of the immune response using antigen-antibody complexes. J. Immunol. 112:804-11
88. Nie X, Basu S, Cerny J. 1997. Immunization with immune complex alters the repertoire of antigen-reactive B cells in the germinal centers. Eur. J. Immunol. 27:3517-25
89. Kunkl A, Klaus GGB. 1981. The generation of memory cells. IV. Immunization with antigen-antibody complexes accelerates the development of B-memory cells, the formation of germinal centres and the maturation of antibody affinity in the secondary responses. Immunology 43:371-77
90. Hamaoka T, Kitagawa M. 1971. Antibody production in mice. II. The mechanism of antigenic stimulation in the secondary immune response. Immunology 20:191-203
91. Safford JJW, Tokuda S. 1971. Antibody-mediated suppression of the immune response: effect on the development of immunologic memory. J. Immunol. 107:1213-25
92. Enriquez-Rincon F, Klaus GGB. 1984. Follicular trapping of hapten-erythrocyte-antibody complexes in mouse spleen. Immunology 52:107-16
93. Dennert G. 1971. The mechanism of antibody-induced stimulation and inhibition of the immune response. J. Immunol. 106:951-55
94. Murgita RA, Vas SI. 1972. Specific antibody-mediated effect on the immune response: suppression and augmentation of the primary immune response in mice by different classes of antibodies. Immunology 22:319-31
95. Terres G, Wolins W. 1961. Enhanced immunological sensitization of mice by the simultaneous injection of antigen and specific antiserum. J. Immunol. 86:361-68
96. Terres G, Stoner RD. 1962. Specificity of enhanced immunological sensitization of mice following injections of antigens and specific antisera. Proc. Soc. Exp. Biol. Med. 109:88-91
97. Papamichail M, Gutierrez C, Embling P, Johnson P, Holborow EJ, Pepys MB. 1975. Complement dependence of localisation of aggregated IgG in germinal centers. Scand. J. Immunol. 4:343-47
98. Gavin AL, Barnes N, Dijstelbloem HM, Hogarth PM. 1998. Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity. J. Immunol. 160:20-23
99. Hulett MD, Hogarth PM. 1994. Molecular basis of Fc receptor function. Adv. Immunol. 57:1-127
100. Regnault A, Lankar D, Lacabanne V, Rodriguez A, Thery C, Rescigno M, Saito T, Verbeek S, Bonnerot C, Ricciardi-Castagnoli P, Amigorena S. 1999. Fcγ-receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:371-80
101. Ukkonen P, Lewis V, Marsh M, Helenius A, Mellman I. 1986. Transport of macrophage Fc receptors and Fc receptor-bound ligands to lysosomes. J. Exp. Med. 163:952-71
102. Manca F, Fenoglio D, Li Pira G, Kunkl S, Celada F. 1991. Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies. J. Exp. Med. 173:37-48
103. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109-18
104. Heyman B, Hobbs M, Weigle WO. 1985. IgM-mediated enhancement of in vivo anti-sheep erythrocyte antibody responses: isotype analysis of the enhanced responses. Cell. Immunol. 92: 134-41
105. Strannegård Ö, Belin L. 1971. Enhancement of reagin formation in rabbits by passively administered 19S antibody. Immunology 20:427-31
106. Harte PG, Cooke A, Playfair JHL. 1983. Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature 302:256-58
107. Coutinho A, Forni L. 1981. The enhancement of antibody response by IgM antibodies is dependent on antigen-specific T helper cells. Immunobiology 158:182-90
108. Lehner P, Hutchings P, Lydyard PM, Cooke A. 1983. Regulation of the immune response by antibody. II. IgM-mediated enhancement: dependency on antigen dose, T-cell requirement and lack of evidence for an idiotype-related mechanism. Immunology 50:503-9
109. Heyman B, Gustavsson S, Kusakari C, Nose M, Kinoshita T, Tarkowski A, Klareskog L. 1993. Antibody feedback regulation in MRL/lpr mice. J. Autoimmun. 6:437-48
110. Beale D, Feinstein A. 1976. Structure and function of the constant regions of immunoglobulins. Q. Rev. Biophys. 9: 135-80
111. Karush F, Chua M-M, Rodwell JD. 1979. Interaction of a bivalent ligand with IgM anti-lactose antibody. Biochemistry 18: 2226-32
112. Wright JK, Tschopp J, Jaton J-C, Engel J. 1980. Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix complement. Biochem. J. 187:775-80
113. Borsos T, Rapp HJ. 1965. Complement fixation on cell surfaces by 19S and 7S antibodies. Science 150:505-6
114. Jerne NK, Nordin AA. 1963. Plaque formation in agar by single antibody-producing cells. Science 140:405
115. Pepys MB. 1974. Role of complement in induction of antibody production in vivo: effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. Exp. Med. 140:126-45
116. Bitter-Suermann D, Hoffmann T, Burger R, Hadding U. 1981. Linkage of total deficiency of the second component of the complement system and of genetic C2-polymorphism to the major histocompatibility complex of the guinea pig. J. Immunol. 127:608-12
117. Ochs HD, Wedgwood RJ, Frank MM, Heller SR, Hosea SW. 1983. The role of complement in the induction of antibody responses. Clin. Exp. Immunol. 53:208-16
118. Böttger EC, Hoffmann T, Hadding U, Bitter-Suermann D. 1985. Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs. J. Immunol. 135:4100-7
119. Jackson CG, Ochs HD, Wedgwood RJ. 1979. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N. Engl. J. Med. 300:1124-29
120. O'Neil KM, Ochs SR, Heller SR, Cork LC, Morris JM, Winkelstein JA. 1988. Role of C3 in humoral immunity: defective antibody production in C3-deficient dogs. J. Immunol. 140:1939-45
121. Fischer MB, Ma M, Goerg S, Zhou X, Xia J, Finco O, Han S, Kelsoe G, Howard RG, Rothstein TL, Kremmer E, Rosen FS, Carroll MC. 1996. Regulation of the B cell response to T-dependent Ags by classical pathway complement. J. Immunol. 157:549-56
122. Matsumoto M, Fukuda W, Circolo A, Goellner J, Strauss-Schoenberger J, Wang X, Fujita S, Hidvegi T, Chaplin DD, Colten HR. 1997. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. USA 94:8720-25
123. Turner MW. 1996. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today 17: 532-40
124. Ahearn JM, Fischer MB, Croix D, Goerg S, Ma M, Xia J, Zhou X, Howard RG, Rothstein TL, Carroll MC. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251-62
125. Croix DA, Ahearn JM, Rosengard AM, Han S, Kelsoe G, Ma M, Carroll MC. 1996. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183:1857-64
126. Molina H, Holers VM, Li B, Fang Y-F, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Chaplin DD. 1996. Markedly impaired humoral immune responses in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93:3357-61
127. Heyman B, Wiersma EJ, Kinoshita T. 1990. In vivo inhibition of the antibody response by a monoclonal complement receptor specific antibody. J. Exp. Med. 172: 665-68
128. Wiersma EJ, Kinoshita T, Heyman B. 1991. Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors. Eur. J. Immunol. 21:2501-6
129. Thyphronitis G, Kinoshita T, Inoue K, Schweinle JE, Tsokos GC, Metcalf ES, Finkelman FD, Balow JE. 1991. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J. Immunol. 147:224-30
130. Hebell T, Ahearn JM, Fearon DT. 1991. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254:102-5
131. Kurtz CB, O'Toole E, Christensen SM, Weis JH. 1990. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144:3581-91
132. Fearon DT, Carter RH. 1995. The CD19/ CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:127-49
133. Fang Y, Xu C, Fu Y-X, Holers VM, Molina H. 1998. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160:5273-79
134. Carter RH, Fearon DT. 1992. CD 19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105-7
135. Thornton BP, Vetvicka V, Ross GD. 1994. Natural antibody and complement-mediated antigen processing and presentation by B-lymphocytes. J. Immunol. 152:1727-37
136. Boackle SA, Morris MA, Holers VM. 1998. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J. Immunol. 161:6537-43
137. Gustavsson S, Kinoshita T, Heyman B. 1995. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T-helper cell induction. J. Immunol. 154:6524-28
138. Davies KA, Erlendsson K, Beynon HLC, Peters AM, Steinsson K, Valdimarsson H, Walport MJ. 1993. Splenic uptake of immune complexes in man is complement-dependent. J. Immunol. 151:3866-73
139. Qin D, Wu J, Carroll MC, Burton GF, Szakal AK, Tew JG. 1998. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses. J. Immunol. 161:4549-54
140. Ochs HD, Nonoyama S, Zhu Q, Farrington M, Wedgwood RJ. 1993. Regulation of antibody responses: the role of complement and adhesion molecules. Clin. Immunol. Immunopathol. 67:S33-40
141. Martinelli GP, Matsuda T, Osler AG. 1978. Studies of immunosuppression by cobra venom factor. I. On early IgG and IgM responses to sheep erythrocytes and DNP-protein conjugates. J. Immunol. 121:2043-47
142. Böttger EC, Hoffmann T, Metzger S, Hadding U, Bitter-Suermann D. 1986. The role and mechanism of cobra venom factor-induced suppression of the humoral immune response in guinea pigs. J. Immunol. 137:1280-85
143. Hjulström S, Landin A, Jansson L, Holmdahl R, Heyman B. 1995. No role of interleukin-4 in CD23/IgE-mediated enhancement of the murine antibody response in vivo. Eur. J. Immunol. 25:1469-72
144. Westman S, Gustavsson S, Heyman B. 1997. Early expansion of secondary B cells after primary immunization with antigen complexed with IgE. Scand. J. Immunol. 46:10-15
145. Delespesse G, Sarfati M, Wu CY, Fournier S, Letellier M. 1992. The low-affinity receptor for IgE. Immunol. Rev. 125:77-97
146. Sutton BJ, Gould HJ. 1993. The human IgE network. Nature 366:421-28
147. Bonnefoy JY, Lecoanet-Henchoz S, Gauchat JF, Graber P, Aubry JP, Jeannin P, Plater-Zyberk C. 1997. Structure and functions of CD23. Int. Rev. Immunol. 16:113-28
148. Squire CM, Studer EJ, Lees A, Finkelman FD, Conrad DH. 1994. Antigen presentation is enhanced by targeting antigen to the FcεRII by antigen-antiFcεRII conjugates. J. Immunol. 152: 4388-96
149. Rao M, Lee WT, Conrad DH. 1987. Characterization of a monoclonal antibody directed against the murine B lymphocyte receptor for IgE. J. Immunology 138:1845-51
150. Maeda K, Burton GF, Padgett DA, Conrad DH, Huff TF, Masuda A, Szakal AK, Tew JG. 1992. Murine follicular dendritic cells and low affinity Fc receptors for IgE (FcεRII). J. Immunol. 148:2340-47
151. Kondo H, Ichikawa Y, Nakamura K, Tsuchiya S. 1994. Cloning of cDNAs for new subtypes of murine low-affinity Fc receptor for IgE (FcεRII/CD23). Int. Arch. Allergy Immunol. 105:38-48
152. Conrad DH, Kozak CA, Vernachio J, Squire CM, Rao M, Eicher EM. 1993. Chromosomal location and isoform analysis of mouse FcεRII/CD23. Mol. Immunol. 30:27-33
153. Kehry MR, Yamashita LC. 1989. Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing. Proc. Natl. Acad. Sci. USA 86:7556-60
154. Pirron U, Schlunck T, Prinz JC, Rieber EP. 1990. IgE-dependent antigen focusing by human B lymphocytes is mediated by low-affinity receptor for IgE. Eur. J. Immunol. 20:1547-51
155. Santamaria LF, Bheekha R, van Reijsen FC, Perez Soler MT, Suter M, Bruijnzeel-Koomen CAFM, Mudde GC. 1993. Antigen focusing by specific monomeric immunoglobulin E bound to CD23 on Epstein-Barr virus-transformed B cells. Hum. Immunol. 37:23-30
156. van der Heijden FL, van Neerven RJJ, van Katwijk M, Bos JD, Kapsenberg ML. 1993. Serum-IgE-facilitated allergen presentation in atopic disease. J. Immunol. 150:1-8
157. Bheekha Escura R, Wasserbauer E, Hammerschmid F, Pearce A, Kidd P, Mudde GC. 1995. Regulation and targeting of T-cell immune responses by IgE and IgG antibodies. Immunology 86:343-50
158. Campbell KA, Lees A, Finkelman FD, Conrad DH. 1992. Co-crosslinking FcεRII/CD23 and B cell surface immunoglobulin modulates B cell activation. Eur. J. Immunol. 22:2107-12
159. Aubry J-P, Pochon S, Graber P, Jansen KU, Bonnefoy J-Y. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505-7
160. Lecoanet-Henchoz S, Gauchat J-F, Aubry J-P, Graber P, Life P, Paul-Eugene N, Ferrua B, Corbi AL, Dugas B, Plater-Zyberk C, Bonnefoy J-Y. 1995. CD23 regulates monocyte activation through a novel interaction with adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 3:119-25
161. Lecoanet-Henchoz S, Plater-Zyberk C, Graber P, Gretener D, Aubry J-P, Conrad D, Bonnefoy J-Y. 1997. Mouse CD23 regulates monocyte activation through an interaction with the adhesion molecule CD11b/CD18. Eur. J. Immunol. 27:2290-94
162. Davey EJ, Bartlett WC, Kikutani H, Fujiwara H, Kishimoto T, Conrad DH, Severinson E. 1995. Homotypic aggregation of murine B lymphocytes is independent of CD23. Eur. J. Immunol. 25:1224-29
163. Yu P, Kosco-Vilbois M, Richards M, Köhler G, Lamers MC. 1994. Negative feedback regulation of IgE synthesis by murine CD23. Nature 369:753-56
164. Texido G, Eibel H, Le Gros G, van der Putten H. 1994. Transgene CD23 expression on lymphoid cells modulates IgE and IgG1 responses. J. Immunol. 153: 3028-42
165. Payet ME, Woodward EC, Conrad DH. 1999. Humoral response suppression observed with CD23 transgenics. J. Immunol. 163:217-23
166. Christie G, Barton A, Bolognese B, Buckle DR, Cook RM, Hansbury MJ, Harper GP, Marshall LA, McCord ME, Moulder K, Murdock PR, Seal SM, Spackman VM, Weston BJ, Mayer RJ. 1997. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (FcεRII). Eur. J. Immunol. 27:3228-35
167. Flores-Romo L, Shields J, Humbert Y, Graber P, Aubry J-P, Gauchat J-F, Ayala G, Allet B, Chavez M, Bazin H, Capron M, Bonnefoy J-Y. 1993. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science 261:1038-41
168. Plater-Zyberk C, Bonnefoy J-Y. 1995. Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo. Nat. Med. 1:781-85
169. Kleinau S, Martinsson P, Gustavsson S, Heyman B. 1999. Importance of CD23 for collagen-induced arthritis: delayed onset and reduced severity in CD23-deficient mice. J. Immunol. 162:4266-70
170. Siskind GW, Dunn P, Walker JG. 1968. Studies on the control of antibody synthesis. II. Effect of antigen dose and of suppression by passive antibody on the affinity of antibody synthesized. J. Exp. Med. 127:55-66
171. Shigeoka AO, Jensen CL, Pincus SH, Hills HR. 1984. Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci. J. Infect. Dis. 150:63-70
172. Wessels MR, Butko P, Ma M, Warren HB, Lage AL, Carroll MC. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 and C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92:11490-94
173. Stief A, Texido G, Sansig G, Eibel H, Le Gros G, van der Putten H. 1994. Mice deficient in CD23 reveal its modulatory role in IgE production but no role in T and B cell development. J. Immunol. 152:3378-90
174. Carter RH, Spycher MO, Ng YC, Hoffmann R, Fearon DT. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B-lymphocytes. J. Immunol. 141:457-63
175. Gustavson S, Wernersson S, Hayman B. 2000. Restoration of the antibody response to IgE/antigen complexes in CD23-deficient mice by CD23 + spleen or bone marrow cells. J. Immunol. In press